RIPE-KG · Version 1.1.0 · Resource
ripekg:work/10.1007%2Fs00192-017-3445-x
https://w3id.org/ripe/ripe-kg/work/10.1007%2Fs00192-017-3445-x
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1007%2Fs00192-017-3445-xDiscontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse |
prism:doi |
10.1007/s00192-017-3445-x |
ripekg:work/10.1007%2Fs00192-017-3445-xDiscontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse |
dcterms:title |
Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse |
ripekg:work/10.1007%2Fs00192-017-3445-xDiscontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse |
rdf:type |
node1 |
ripekg:work/10.1007%2Fs00192-017-3445-xDiscontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1007%2Fs00192-017-3445-xDiscontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse |
rdf:type |
rdfs:Resource |
ripekg:work/10.1007%2Fs00192-017-3445-xDiscontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse |
rdf:type |
owl:Thing |
ripekg:work/10.1007%2Fs00192-017-3445-xDiscontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse |
rdf:type |
prov:Entity |
ripekg:work/10.1007%2Fs00192-017-3445-xDiscontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1007%2Fs00192-017-3445-xDiscontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse |
owl:sameAs |
https://semopenalex.org/work/W2746071582 |
ripekg:work/10.1136%2Fbmj-2025-084418Effects of intravaginal conjugated oestrogen on pessary continuation for pelvic organ prolapse: multicentre, randomised, double blind, placebo controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/10.1007%2Fs00192-017-3445-xDiscontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse |
ripekg:work/10.1136%2Fbmj-2025-084418Web appendix 1: Supplementary protocol Web appendix 2: Supplementary appendix the bmj |
http://purl.org/spar/cito/cites |
ripekg:work/10.1007%2Fs00192-017-3445-xDiscontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse |